Artificial intelligence (AI), healthcare and business-to-business (B2B) fintech are emerging as key investment opportunities in India’s startup ecosystem, with investors increasingly looking at technology-led solutions to address gaps in healthcare delivery, financial services and traditional businesses. Investors believe patient capital, sustainable business models and wider technology adoption will be critical to building the next generation of Indian startups.
At a panel discussion at the Shubh Lab Startup Summit by Favcy, investors discussed emerging sectors, investment opportunities and changing venture capital priorities. The discussion highlighted opportunities in AI-led preventive healthcare, drug discovery, healthtech-fintech convergence, SME lending, logistics and supply chain. Investors also emphasised the need for patient capital, stronger credit strategies and better market access for deeptech startups to turn innovations into commercially viable businesses.
AI-Led Healthcare, Preventive Care To Attract Investments
Investors see significant opportunities in healthcare, particularly in the application of AI across preventive healthcare, drug discovery, genomics and personalised treatment.
Vishal Gandhi said India’s healthcare system needs to transition from a predominantly sick-care model towards preventive healthcare, with AI enabling individuals to take greater control of their health.
“India needs to transition from sick care to preventive healthcare. AI can play a significant role in the consumerisation of healthcare, allowing individuals to take charge of their own health management,” Gandhi said.
He also highlighted the potential of AI in accelerating drug discovery, where analysing large volumes of data could help researchers identify failures faster and improve the development process.
“Drug discovery is a game of failures. The real opportunity lies in using AI to ensure that we fail faster,” Gandhi said.
Gandhi further pointed to opportunities in consumer genomics and microbiome analysis, where AI can help analyse health data and generate insights that can support more personalised healthcare.
Healthtech-Fintech Convergence Opens New Opportunities
The intersection of healthcare and financial technology is another area attracting investor interest, particularly in addressing the financing gap for medical treatments.
Paramdeep Singh highlighted the scale of uninsured healthcare expenses, pointing to opportunities for fintech and healthtech startups to develop financing solutions for patients who struggle to arrange funds for medical procedures.
“Close to $50 billion of health expenses are not insured,” Singh said, adding that patients often have to arrange funds before proceeding with medical treatment.
He said AI-enabled point-of-care financing solutions could help assess patients’ credit requirements and facilitate access to funds, allowing patients to access treatment faster.
Singh also highlighted the growing interest in wellness and longevity, arguing that longer life expectancy needs to be accompanied by better health outcomes.
“If Indians are going to live until the age of 90, you want a health span that is also good,” he said.
B2B Fintech, SME Lending To Attract Capital
Beyond consumer-facing financial technology, investors see significant opportunities in B2B fintech, particularly in SME lending, collections and credit management.
Paramdeep Singh said businesses addressing operational challenges in traditional sectors could create substantial value, with AI improving efficiency and enabling them to scale.
“Boring fintech businesses, particularly those operating in B2B, SME lending, collections and credit, are where the real money will be made as the sector scales,” Singh said.
He added that lending businesses need to focus on credit assessment and recovery rather than simply expanding loan disbursements.
“Any NBFC can stand in a corner and give out loans. The real expertise lies in getting the credit strategy right and ensuring that the money comes back,” Singh said.
On consumer fintech, Singh said distribution would remain a critical factor in determining the long-term value of businesses, rather than product differentiation alone.
“In consumer fintech, the money is not necessarily in the product; it is in distribution,” he said.
Patient Capital Needed To Build India’s AI Companies
Nitin Sethi highlighted the need for patient capital to support startups working on emerging technologies and business models that may require longer periods to scale.
He said India has traditionally lacked a strong track record of patient investing, which could affect the ability of startups to build large businesses in emerging sectors.
“India does not have a proven track record in patient capital. We have traditionally been hesitant to invest patiently, whether as angel investors or through Category I, II and III funds,” Sethi said.
He added that opportunities extend beyond conventional technology sectors, including B2B-to-consumer businesses, consumer technology and travel technology, particularly in Tier II and Tier III markets.
“We have hardly seen multi-billion-dollar AI companies emerge from India. That can happen only when we have patient capital and operators who can work together to create a multiplier effect,” Sethi said.
Sethi also identified logistics and supply chain as sectors with significant potential, particularly in addressing inefficiencies across the agricultural value chain.
“Logistics and supply chain are sectors I would love to back. This sector can address the entire produce-to-table problem,” he said.
Deeptech Startups Need Better Market Access
Gandhi also highlighted the challenges faced by deeptech startups in taking innovations from research and development to commercial adoption.
He expressed government procurement processes and the emphasis on the lowest-price criteria in tenders could make it difficult for startups that invest significantly in research and development to compete with established players.
“The government is promoting research and development, but it also needs to ensure that the products developed by startups are adopted,” Gandhi said.
He argued that procurement mechanisms need to recognise innovation and create opportunities for startups to commercialise their products.
Gandhi added that several research institutions and startups are developing solutions to problems such as air pollution, but many struggle to secure the visibility and funding needed to scale their innovations.
AI, Business Fundamentals To Shape Startup Investments
The investors’ discussion highlighted a shift towards businesses addressing fundamental market gaps, with AI increasingly becoming an enabler across healthcare, financial services, logistics and other traditional sectors. They also emphasised that access to patient capital, strong business fundamentals and the ability to achieve commercial adoption will remain important for startups seeking to scale.